Skip to content

Jianjing Cao

3 papers in the library · 40 citations · publishing 2013-2021

Papers

Sort Most recent Most cited

Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters.

ACS Pharmacology & Translational Science April 9, 2021 Shreyas Bhat, Daryl A. Guthrie, Ameya Kasture et al. 37 citations

Missense mutations that give rise to protein misfolding are rare, but collectively, defective protein folding diseases are consequential. Folding deficiencies are amenable to pharmacological correction (pharmacochaperoning), but the underlying mechanisms remain enigmatic. Ibogaine and its active metabolite noribogaine correct folding defects in the dopamine transporter (DAT), but they rescue...

A tropane-based ibogaine analog rescues folding-deficient SERT and DAT

bioRxiv (Cold Spring Harbor Laboratory) July 14, 2020 Shreyas Bhat, Daryl A. Guthrie, Ameya Kasture et al. 3 citations preprint

Abstract Missense mutations that give rise to protein misfolding are rare, but collectively, defective protein folding diseases are consequential. Folding deficiencies are amenable to pharmacological correction (pharmacochaperoning), but the underlying mechanisms remain enigmatic. Ibogaine and its active metabolite noribogaine correct folding defects in the dopamine transporter (DAT), but they...

Discriminative‐stimulus effects of 3,4‐methylenedioxy‐N‐methylamphetamine (MDMA) and a novel MDMA quatenary analog

The FASEB Journal April 1, 2013 Jonathan M. Slezak, Melanie Mueller, George A. Ricaurte et al.

MDMA (ecstasy), popularized as a “club drug,” is a psychoactive and abused substance. It is often assumed that the behavioral effects of MDMA are due to central actions, though this has not been tested. Using a quaternary analog of MDMA (qMDMA) we tested that assumption by training male Sprague‐Dawley rats (n = 6) to discriminate intraperitoneal (i.p.) injections of 1.7 mg/kg of MDMA HCl from...